SERPINA1 and inflammatory bowel disease: In our analysis, we found human endogenous protease inhibitors such as Serpins A1 significantly increased in IBD (particularly CD) fecal and MLI samples (Additional file 1: Fig. S7a), probably because the increased protease activity triggers the production of a higher level of protease inhibitors in order to control the destructive nature of protease.